1012.62.111 Boehringer Ingelheim Investigational Site

Rochester, New York

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease — Completed